Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Mar 1;179(3):1011-5.
doi: 10.1084/jem.179.3.1011.

Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules

Affiliations

Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules

K P Kane. J Exp Med. .

Abstract

Ly-49 is a recently identified cell surface molecule expressed on a subpopulation of natural killer (NK) cells and certain T lymphomas. It has been suggested, based on gene transfection and antibody blocking studies, that Ly-49 is a negative regulator of NK lytic activity, possibly through an interaction with target cell class I molecules. However, it has not been demonstrated that class I molecules indeed serve as ligands for Ly-49. We have found that T lymphomas expressing Ly-49 bind isolated class I major histocompatibility complex (MHC) molecules but not class II molecules immobilized on plastic. Adhesion to class I molecules was not found with T lymphomas lacking Ly-49 expression. The Ly-49 expressing EL4 lymphoma bound Dd, Dk, and Kb, but not Kd, Kk, or Db, thus demonstrating a restricted pattern of class I adhesion. The observed cell adhesion was class I density dependent, and binding to Dd and Dk was extensively inhibited by the A1 monoclonal antibody directed against Ly-49. These results provide direct evidence for Ly-49 serving as a receptor for a subset of class I MHC molecules.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1980 Feb;124(2):533-40 - PubMed
    1. J Exp Med. 1993 Jul 1;178(1):223-9 - PubMed
    1. J Immunol. 1980 Dec;125(6):2555-8 - PubMed
    1. Nature. 1982 Dec 23;300(5894):755-7 - PubMed
    1. J Immunol. 1983 Nov;131(5):2178-83 - PubMed

Publication types

MeSH terms

Substances